Literature DB >> 21210169

Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010.

S Butt1, M Idrees, M Shahid, I Amin, S Younas, S Afzal, H Akbar, I Ur Rehman.   

Abstract

The changing pattern in hepatitis C virus (HCV) clades overtime is not well known in Pakistan. To find out the changing pattern of different HCV clades over time in this country 22,125 patients were genotyped and tracked for a period of 11 years (2000-2010). A changing pattern in HCV clades was seen in this region during the study period. Sub-clade 3a remained the dominant sub-clade circulating in different areas of the country in the study era. HCV sub-clade 3a demonstrated significantly high correlation with time (p < 0.05) whereas undetermined clades were seen with statistically non-significant correlation with time (years). All the other clades showed negative correlation with time. In general a significant decline was observed in the percentages of HCV clades 2, 4, 5 and 6 (p < 0.001). Among sub-clades, HCV 1a, 2c, 2b and 3b significantly decreased overtime (p < 0.05), while an increase has been observed for HCV 3a sub-clade and mixed clades (p <0.001). The ratio of undetermined clades remained constant over the study period. In conclusion, a changing pattern of HCV clades was observed over the 11-year study period, and this changed pattern might have direct impact on HCV disease outcome.

Entities:  

Mesh:

Year:  2011        PMID: 21210169     DOI: 10.1007/s10096-010-1138-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  25 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

Authors:  G Dusheiko; J Main; H Thomas; O Reichard; C Lee; A Dhillon; S Rassam; A Fryden; H Reesink; M Bassendine; G Norkrans; T Cuypers; N Lelie; P Telfer; J Watson; C Weegink; P Sillikens; O Weiland
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

3.  New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.

Authors:  O Ohno; M Mizokami; R R Wu; M G Saleh; K Ohba; E Orito; M Mukaide; R Williams; J Y Lau
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.

Authors:  Belén Ramos; Marina Núñez; Carlos Toro; Julie Sheldon; Javier García-Samaniego; Pilar Ríos; Vincent Soriano
Journal:  J Infect       Date:  2006-03-29       Impact factor: 6.072

5.  Modelling how ribavirin improves interferon response rates in hepatitis C virus infection.

Authors:  Narendra M Dixit; Jennifer E Layden-Almer; Thomas J Layden; Alan S Perelson
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

Review 6.  Clinical significance of hepatitis C virus genotypes.

Authors:  N N Zein
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Prevalence of hepatitis C virus (HCV) genotypes and increase of type 4 in central Italy: an update and report of a new method of HCV genotyping.

Authors:  Maria Cenci; Mario Massi; Mauro Alderisio; Gennaro De Soccio; Olga Recchia
Journal:  Anticancer Res       Date:  2007 Mar-Apr       Impact factor: 2.480

8.  High prevalence of hepatitis C virus infection in the largest province of Pakistan.

Authors:  Muhammad Idrees; Amreek Lal; Muhammad Naseem; Muhammad Khalid
Journal:  J Dig Dis       Date:  2008-05       Impact factor: 2.325

9.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

10.  Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution.

Authors:  M Martell; J I Esteban; J Quer; J Genescà; A Weiner; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  1 in total

Review 1.  A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges.

Authors:  Muhammad Ali; Samia Afzal; Asad Zia; Ahmed Hassan; Ali Talha Khalil; Muhammad Ovais; Zabta Khan Shinwari; Muhammad Idrees
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.